Skip to main content
GENETIC TECHNOLOGIES LIMITED logo

GENETIC TECHNOLOGIES LIMITED — Investor Relations & Filings

Ticker · GTG ISIN · AU000000GTG7 LEI · 529900YYKY7FRC90M744 ASX Human health and social work activities
Open in API
Filings indexed 1,303 across all filing types
Latest filing 2005-03-15 Regulatory Filings
Country AU Australia
Listing ASX GTG

About GENETIC TECHNOLOGIES LIMITED

https://gtglabs.com/

Genetic Technologies Limited is a molecular diagnostics company focused on the development and commercialization of predictive genetic risk assessment tools. The company specializes in the geneType platform, which integrates clinical risk factors with polygenic risk scores to provide comprehensive risk assessments for various chronic diseases. Its portfolio includes tests for breast cancer, colorectal cancer, prostate cancer, melanoma, type 2 diabetes, and coronary artery disease. By identifying individuals at high risk of developing these conditions, the company enables healthcare providers to implement personalized screening and preventative health strategies. Genetic Technologies Limited serves clinicians and patients globally, aiming to improve health outcomes through early detection and precision medicine.

Recent filings

Filing Released Lang Actions
Notice of Pending Expiry of Options 5 pages ?Kb
Regulatory Filings
2005-03-15 English
Half Yearly Report & Half Year Accounts 17 pages ?Kb
Regulatory Filings
2005-02-23 English
Reports on further legal activity in New Zealand 1
Regulatory Filings
2005-02-22 English
Reports on further legal activities to protect its patents 1
Regulatory Filings
2005-02-17 English
Grants commercial license to AGRF 1 page ?Kb
Capital/Financing Update Classification · 90% confidence The document is an ASX announcement dated January 31, 2005, reporting that Genetic Technologies Limited has granted a license to the Australian Genome Research Facility. The content focuses on a licensing agreement and commercial terms, with no financial statements, earnings data, or regulatory filings referenced. The document length is short (1943 characters) and it is an announcement of a business development rather than a financial report or regulatory filing. Therefore, it fits best under the category of Capital/Financing Update (CAP), as it relates to licensing agreements which can be considered part of financing or capital activities.
2005-01-30 English
Commitments Test Entity - Second Quarter Report 9 pages ?Kb
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Quarterly Activities Report' and includes detailed operational updates, licensing agreements, research and development progress, corporate matters including board changes, and an Appendix 4C cash flow statement for the quarter ended 31 December 2004. The presence of substantive financial data such as cash flow statements and detailed business activities for a specific quarter indicates this is a comprehensive interim financial report. The document is approximately 15,000 characters long, which supports it being a full report rather than a brief announcement. The quarterly period and financial data align with the definition of an Interim / Quarterly Report (IR). There is no indication that this is merely an announcement or a certification, nor is it a full annual report or earnings release. Therefore, the correct classification is Interim / Quarterly Report (IR).
2005-01-30 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.